Printer-friendly version

Quotations referenced across the site sorted by date of post (descending). Click on the (light-blue) link(s) above the quotation to view the quotation within the context of an article. Quotations without links are pending for articles yet-to-be-published. Click here for a simple alphabetical listing of quotations

We would go to these CEO conferences and it was clear the only intent was for the CEO’s to be able to show off the size of their corporate jets, the beauty of their trophy brides, and to brag on the magnificence of their personal accouterments. It had nothing to do with corporate business. DIA Pharmaceutical Industry Survey+ Participant

We were brought in to automate a very tedious operation in research. The scientists would look through a microscope and perform a simple count of the number of diseased cells on each plate. They used those handheld clickers you see used all the time to count the number of people in a line or in a room. They had a dozen or so of the clickers. We noticed in the data that many of the counts clustered around the numbers 64 and 92. It seemed strange that these counts would show up so often. It turned out that two of the clickers had flaws. One would stick at 64 and the other at 92. Nobody had noticed. I’ll never use pharmaceutical products again. Pharmaceutical Industry Consultant (2009). Personal Communication

We set up an outsourcing mechanism that allowed molecular biologists to go from finding one valid target per week to 30. Don’t know if that meant anything though. DIA Pharmaceutical Industry Survey+ Participant

We have one of the best electronic patient record systems of any major hospital group, and looking back over the history of coronary stents we predicted that if we consistently perform these 19 procedures, then we could dramatically reduce complications, re-admits, emergency visits, and a host of other costs down the line. We cut a sweetheart deal with one of our insurance providers to split the difference in savings. We would perform the 19 procedures for every patient receiving a stent, we would charge fixed fees to the insurance provider, and we would take responsibility for future costs due to complications, re-admits, etc. For 7 quarters we made good profits on this deal. Then in the 8th quarter we lost it all. Our losses in that one quarter exceeded all the gains we had made to-date with the program. CEO, Major Hospital Group (2008). National Academies of Sciences conference on Containment of Health Care Costs

We have met the enemy and he is us Pogo

We don’t want our researchers distracted with commercial concerns. Pharmaceutical Industry Client (2007). Personal Communication

Today’s crop of senior latent fingerprint examiners rose through the ranks as novice examiners who spent several years classifying, filing, and retrieving [manual fingerprint cards]. Latent fingerprint examiners universally attest that this long period of [manual card] work allowed them to develop the visual skills necessary for more advanced fingerprint work: how to orient themselves among the whorls of fingerprinting patterns and how to visually analyze fingerprint patterns ... crucial when examiners try to read a poor-quality latent print. Essentially, this period of [manual card work] taught examiners to see fingerprint patterns in a way quite different from the way the rest of us see them...[Computer automation] brought about a profound change in the training of latent fingerprint examiners. [Manual cards] no longer serves as a training ground for examiners. It is not clear how this aspect of training is going to be replaced ... [Computer automation] threatens to erode the skill level of latent fingerprint examiners. Cole, Simon A. (2002). Suspect Identities, p. 256

There exists in such a case a certain institution or law; let us say, for the sake of simplicity, a fence or gate erected across a road. The more modern type of reformer goes gaily up to it and says, "I don't see the use of this; let us clear it away." To which the more intelligent type of reformer will do well to answer: "If you don't see the use of it, I certainly won't let you clear it away. Go away and think. Then, when you can come back and tell me that you do see the use of it, I may allow you to destroy it." Chesterton, Gilbert K. (1929). The Thing

There once was a man name of Gödel.

Whose work gave logicians a hurdle.

All talk’s incomplete.

It can never defeat.

The hooks on a pure maiden’s girdle.

WCRDAdmin (2010)

There is one question to answer in the decision-making process. “If I do x, will it allow me to more so be who I want to be, or not?” It sounds simple, and it is. Because of the way the question is asked the answer will be yes or no. This decision process is unique and distinct for each individual. If it's a 'Yes', then go ahead. If it's a 'No', do not do it. Illustrative Management Advice Website Text (~2009)